Cerebral Therapeutics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Out of Business

Cerebral Therapeutics General Information

Description

Developer of combination therapies designed to improve the lives of patients suffering from chronic neurological diseases. The company's therapies utilize reformulated off-patent drugs delivered to the ventricles of the brain to bypass the blood-brain barrier, enabling the medical community to improve treatment outcomes related to conditions involving the central nervous system.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 3510 Hopkins Place North
  • Building 4, Suite 233A
  • Oakdale, MN 55128
  • United States
+1 (303)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 3510 Hopkins Place North
  • Building 4, Suite 233A
  • Oakdale, MN 55128
  • United States
+1 (303)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cerebral Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 04-Apr-2025 Completed Out of Business
3. Later Stage VC (Series C) 28-Jun-2022 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series B) 07-Jan-2020 $35M $46M Completed Clinical Trials - Phase 2
1. Later Stage VC (Series A) 08-Mar-2019 $11M $11M Completed Clinical Trials - Phase 2
To view Cerebral Therapeutics’s complete valuation and funding history, request access »

Cerebral Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 290,276 $0.000100 8% $38.24 $38.24 1x $38.24 0.19%
To view Cerebral Therapeutics’s complete cap table history, request access »

Cerebral Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of combination therapies designed to improve the lives of patients suffering from chronic neurological disease
Drug Discovery
Oakdale, MN
19 As of 2022

South San Francisco, CA
 

Clarksville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cerebral Therapeutics Competitors (4)

One of Cerebral Therapeutics’s 4 competitors is Neurona Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
NeuroNascent Venture Capital-Backed Clarksville, MD
Neurogene Formerly VC-backed New York, NY
NeuroPace Formerly VC-backed Mountain View, CA
To view Cerebral Therapeutics’s complete competitors history, request access »

Cerebral Therapeutics Patents

Cerebral Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024097199-A1 Implantable cranial medical device Inactive 01-Nov-2022
WO-2023224869-A2 Implantable medical device and system Inactive 16-May-2022
WO-2023224869-A3 Implantable medical device and system Inactive 16-May-2022
WO-2023158617-A1 Implantable medical device for use with or having recording electrode Inactive 15-Feb-2022
WO-2023129532-A1 Ventricular drain or shunt assembly with recording electrode Inactive 29-Dec-2021 A61B5/293
To view Cerebral Therapeutics’s complete patent history, request access »

Cerebral Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cerebral Therapeutics FAQs

  • When was Cerebral Therapeutics founded?

    Cerebral Therapeutics was founded in 2010.

  • Where is Cerebral Therapeutics headquartered?

    Cerebral Therapeutics is headquartered in Oakdale, MN.

  • What is the size of Cerebral Therapeutics?

    Cerebral Therapeutics has 19 total employees.

  • What industry is Cerebral Therapeutics in?

    Cerebral Therapeutics’s primary industry is Drug Discovery.

  • Is Cerebral Therapeutics a private or public company?

    Cerebral Therapeutics is a Private company.

  • What is Cerebral Therapeutics’s current revenue?

    The current revenue for Cerebral Therapeutics is .

  • How much funding has Cerebral Therapeutics raised over time?

    Cerebral Therapeutics has raised $86M.

  • Who are Cerebral Therapeutics’s competitors?

    Neurona Therapeutics, NeuroNascent, Neurogene, and NeuroPace are competitors of Cerebral Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process